v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 18,249 $ 27,605
Prepaid expenses and other current assets 6,552 5,109
Total current assets 24,801 32,714
Other assets 23 15
Total assets 24,824 32,729
Current liabilities:    
Accounts payable 2,168 3,687
Accrued and other current liabilities 5,067 2,375
Accrued clinical site costs 751 469
Earnout Cash liability   4,582
Warrant liabilities 56 292
Note payable and accrued interest   518
Total liabilities 8,042 11,923
Preferred stock, $0.001 par value, 50,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value, 500,000,000 shares authorized; 67,641,314 and 58,810,550 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 68 59
Additional paid-in capital 229,470 203,990
Accumulated deficit (212,756) (183,243)
Total stockholders' equity 16,782 20,806
Total liabilities and stockholders' equity $ 24,824 $ 32,729

Source